Minerva Neurosciences, Inc.
NERV
$5.21
-$0.29-5.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 46.33% | -7.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 75.14% | -15.70% | |||
| Operating Income | -75.14% | 15.70% | |||
| Income Before Tax | -10,237.74% | 15.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10,237.74% | 15.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10,237.74% | 15.79% | |||
| EBIT | -75.14% | 15.70% | |||
| EBITDA | -75.17% | 15.71% | |||
| EPS Basic | -6,938.43% | 15.80% | |||
| Normalized Basic EPS | -6,937.25% | 15.79% | |||
| EPS Diluted | -6,938.43% | 15.80% | |||
| Normalized Diluted EPS | -6,937.25% | 15.79% | |||
| Average Basic Shares Outstanding | 46.89% | 0.00% | |||
| Average Diluted Shares Outstanding | 46.89% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||